1:11-cv-00515 | W.L. Gore & Associates Inc. et al v. C.R. Bard Inc. | RPX Insight

W.L. Gore & Associates Inc. et al v. C.R. Bard Inc. DC
- 1:11-cv-00515
- D. Del.
- Judge: Leonard P. Stark
- Filed: 06/10/2011
- Closed: 09/26/2017
- Latest Docket Entry: 03/14/2024
- PACER
- Docket updated daily

2

Plaintiffs

2

Defendants

2

Accused Products

3

Patents-in-Suit

2,301

Days in Litigation

Docket (942 Entries)

W.L. Gore & Associates Inc. et al v. C.R. Bard Inc. DC
- 1:11-cv-00515
- D. Del.
- Judge: Leonard P. Stark
- Filed: 06/10/2011
- Closed: 09/26/2017
- Latest Docket Entry: 03/14/2024
- PACER
- Docket updated daily

Docket (942 Entries)

Litigation Complaint | RPX Insight

View Complaint

Cause of Action

Willful Patent Infringement

Market Sector

Biotech and Pharma

Court

District of Delaware

Assigned Judge

Leonard P. Stark

Outcome Summary

View Outcome Details

Validity and Enforceability Details

Infringement Details

Patent Information

Patents-in-Suit

Validity & Enforceability

US 5,735,892 A

3 Details

Claim #	Claim Text	Outcome
32	A tubular intraluminal graft comprising: a) a tubular, diametrically adjustable stent having an exterior surface, a luminal surface and a wall, and having a multiplicity of openings through the wall of the stent; b) a first tubular covering of porous expanded polytetrafluoroethylene affixed to the exterior surface of the tubular, diametrically adjustable stent; and c) a second tubular covering of porous expanded polytetrafluoroethylene affixed to the luminal surface of the tubular, diametrically adjustable stent; wherein the combined thickness of the first and second tubular coverings is less than about 0.10 mm thick exclusive of the stent. view more	Invalid (102 and 103) Entry 779
40	A tubular intraluminal graft according to claim 32 wherein the tubular diametrically adjustable stent is a Nitinol stent.	Invalid (102 and 103) Entry 779
All Claims	NA	Valid (112) Entry 491

US 5,700,285 A

1 Detail

Claim	Outcome
All challenged claims	Valid (112) Entry 491

Infringement

Bard Peripheral Vascular Incorporated

1 Detail

Accused Product	Patent #	Claim #	Outcome
Flair endovascular stent graftFLUENCY Plus Tracheobronchial Stent Graft	US 5,735,892 A	All Asserted Claims	Infringement Entry 491

C.R. Bard, Inc.

2 Details

Accused Product	Patent #	Claim #	Outcome
Flair endovascular stent graft	US 5,700,285 A	All Asserted Claims	No infringement Entry 405
Flair endovascular stent graftFLUENCY Plus Tracheobronchial Stent Graft	US 5,735,892 A	All Asserted Claims	Infringement Entry 491 Entry 405

1 Detail

Accused Product	Patent #	Claim #	Outcome
Bard's Flair productBard's Fluency Plus product	US 5,735,892 A	32, 40	No infringement Entry 779